Shareholder information
Home / Investor relations / Shareholder information
The Board's aim is to strike a balance between the interest of the business, our financial creditors and our shareholders. Dividends will normally be paid twice a year, with a greater proportion paid as a second interm.
Upcoming events
Annual General Meeting and General Meeting information
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Shareholder forms
You can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the Equiniti Shareview website.
Completed forms should be returned to:
Equiniti
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA
For more information, shareholder services and changes to personal details, visit the Equiniti website.
Tax information: Alexion
You can download a copy of Form 8937 prepared in relation to the Alexion transaction here. This form will be available on the AstraZeneca website until 31 December 2031.
Investor enquiries
Main Contacts
![Andy Barnett](/content/dam/az/Investor_Relations/contacts/Andy-Barnett-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Andy-Barnett-2024.jpg)
Andy Barnett
Head of Investor Relations
![Isabel Gibson](/content/dam/az/Investor_Relations/contacts/Isabel-Gibson-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Isabel-Gibson-2024.jpg)
Isabel Gibson
Oncology
![Christer Gruvris](/content/dam/az/Investor_Relations/contacts/Christer-Gruvris-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Christer-Gruvris-2024.jpg)
Christer Gruvris
BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
Finance & Fixed Income
![Rachel Korolyshun](/content/dam/az/Investor_Relations/contacts/Rachel-Korolyshun-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Rachel-Korolyshun-2024.jpg)
Rachel Korolyshun
Rare Disease,
Environment, Social and Governance
![Morgan Sanford](/content/dam/az/Investor_Relations/contacts/Morgan-Sanford-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Morgan-Sanford-2024.jpg)
Morgan Sanford
Oncology
![Philip Sparks](/content/dam/az/Investor_Relations/contacts/Philip-Sparks-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Philip-Sparks-2024.jpg)
Philip Sparks
BioPharmaceuticals
(Respiratory & Immunology, Vaccines & Immune Therapies)
![Lauren Swales](/content/dam/az/Investor_Relations/contacts/Lauren-Swales-2024.jpg/jcr:content/renditions/cq5dam.web.100.square.Lauren-Swales-2024.jpg)
Lauren Swales
Rare Disease,
Environment, Social and Governance